Herculean Task Awaits New NAFDAC Boss- Adelusi-Adeluyi

2
584

As NAPharm fetes Adeyeye, Babalola for being good ambassadors

As the new helmsman of the National Agency for Food and Drug Administration and Control (NAFDAC) resumes office, Prince Julius Adelusi-Adeluyi, president of the Nigeria Academy of Pharmacy (NAPharm) has warned about the impending hurdles that awaits her.

Speaking at the special reception held in honour of both Prof. Mojisola Adeyeye, director general, NAFDAC and Prof. Chinedum Babalola, vice chancellor of Chrisland University at Sheraton Hotel, Ikeja, Lagos on 1 March 2018, Adelusi-Adeluyi opined that, in spite of the odds facing her, he has no doubt the agency boss has the capacity to overcome them.

“When last September, we inducted Adeyeye into the prestigious ranks of NAPharm’s fellowship, little did we know that the fellowship was in some way a prelude to even bigger things.

-As NAPharm fetes Adeyeye, Babalola for being good ambassadors
L-R: Sir Ifeanyi Atueyi, vice president (South), Nigeria Academy of Pharmacy (NAPharm); Senator Olushola Adeyeye, Senate chief whip; Prof. Mojisola Adeyeye, director general, National Agency for Food and Drug Administration and Control (NAFDAC); Prince Julius Adelusi-Adeluyi, president, NAPharm; Prof. Chinedum Babalola, vice chancellor of Chrisland University; Venerable Olufemi Babalola and Prof. Fola Tayo, secretary general in a group photograph.

“By November, she had been appointed as NAFDAC’s director general. The timing of her appointment is quite auspicious. It is now Adeyeye’s burden to ensure that NAFDAC strives to redress these and other issues such that its role in enthroning and safeguarding the good health of Nigerians becomes increasingly pivotal,” he charged.

He highlighted the enormous task ahead of her

According to the NAPharm president, the state of disorder in the nation’s drug distribution system coupled with porous borders heighten the risk of circulation of fake and substandard medicines, foods and other products, as well as challenge the health and well-being of Nigerians.

With such daunting task, Adelusi-Adeluyi declared that the academy strongly believe that with her experience as a veteran academic, administrator, innovator, holder of several patents and extensive exposure to world class institution like America’s Food and Drug Administration(FDA), it is a job in which the professor of Pharmaceutics is well cut out.

“Clearly, the task before her is herculean. But we believe Nigeria stands to benefit significantly from her unique combination of expertise, innovativeness and enthusiasm to make a difference in NAFDAC.

“While wishing her the very best in her new assignment, we also call on government at different levels to help provide support especially with legislation as well as enforcement to enable NAFDAC delivers impeccably on its mandate,” he stressed.

Prince Adelusi-Adeluyi extols Prof. Chinedum Babalola’s roles

The academy also lauded Prof. Chinedum Babalola, vice chancellor of Chrisland University for having a distinguished career as a drug development expert, researcher, teacher and mentor to young pharmacists as well as administrator at the University of Ibadan.

L-R: Prof. Chinedum Babalola, vice chancellor of Chrisland University; Prince Julius Adelusi-Adeluyi, president, NAPharm and Prof. Mojisola Adeyeye, director general, NAFDAC.

In his words, Adelusi-Adeluyi noted that NAPharm is elated by yet another Fellow of the academy to the position of vice chancellor in Chrisland University.

“We have no doubt whatsoever that her tour of duty at Chrisland University will be most successful. The Nigeria Academy of Pharmacy is an unrepentant and unabashed promoter of excellence.

“We commend our two colleagues on their appointments and exhort them to spare no effort in excelling at their new roles.

They had set a standard in their respective new roles and I enjoin them to continue to look up to God as a compass to guide them,” he admonished.

Adeyeye and Babalola expressed their appreciations to the academy

Expressing appreciation for the honour, the new vice chancellor of Chrisland University declared that her name ‘Chinedum’ (God leads me) is a reflection of her life.

 

L-R: Venerable Olufemi Babalola; his wife, Prof. Chinedum Babalola, vice chancellor of Chrisland University; Prince Julius Adelusi-Adeluyi, president, NAPharm and Sir Ifeanyi Atueyi, NAPharm vice president (South)

“Even when it appeared like I wouldn’t survive as a kid, God has always been with me. I remember how my mum stood by me all through. As a kid, I usually developed malaria every time I had examination.

“My mother was always coming around to administer my medicine. At the end, God’s Will prevailed,” she said.

Babalola who disclosed that she was at first confused when NAPharm conferred her with its fellowship applauded the academy for keeping faith with her.

On her part, Adeyeye explained that her journey through academic to her present appointment was what she called ‘Unmerited Favour.”

“I must not also fail to thank my husband, Senator Olushola Adeyeye, the Senate chief whip for his patience. He is what I call a ‘genius’ because he taught me patience, perseverance and how to respond quickly to situations.

“Many of you were surprised on seeing how early our delegation arrived for today’s event. That is the new NAFDAC you are seeing,” she emphasized.

List of dignitaries at the event

In attendance at the event were Sir Ifeanyi Atueyi, NAPharm vice president (South); Prof. Fola Tayo, secretary general; Pharm Lekan Asuni, managing director, Lefas Pharma; Dr Okey Akpa, chairman, Pharmaceuticals Manufacturers Group of Manufacturers Association of Nigeria (PMG-MAN); Prof. Kemi Odukoya, former dean, Faculty of Pharmacy, University of Lagos (UNILAG) and Pharm. John Nwaiwu, managing director, JB Pharmaceuticals.

Others were Pharm. Nnamdi Obi, chairman, Association of Pharmaceutical Importers of Nigeria (APIN); Dr Chukwuka Obiora, chairman of Greenlife Pharmaceuticals; Mazi Sam Ohuabunwa, former managing director, Neimeth Pharmaceuticals; Pharm. Nnamdi Okafor, managing director, May & Baker Plc; Dr Poly Emenike, chairman of Neros Pharmaceuticals; Pharm. Lere Baale, director, Business School Netherlands; Pharm Ike Onyechi, NAPharm treasurer and Pharm. Remi Adeseun, country manager, IQVIA.

2 COMMENTS

LEAVE A REPLY